Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

OBJECTIVE: In a number of controlled clinical trials and naturalistic studies, aripiprazole once monthly (AOM) has been found to be effective and safe as acute and maintenance treatment options for schizophrenia. However, such clinical data have been presented in selected patient population (i.e., a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Psychopharmacol Neurosci
Autori principali: Pae, Chi-Un, Han, Changsu, Bahk, Won-Myong, Lee, Soo-Jung, Patkar, Ashwin A., Masand, Prakash S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean College of Neuropsychopharmacology 2021
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8077057/
https://ncbi.nlm.nih.gov/pubmed/33888652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2021.19.2.233
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi